Top

Published in:

Open Access 01-12-2024 | Acute Myeloid Leukemia | Research

Regulatory function and mechanism research for m6A modification WTAP via SUCLG2-AS1- miR-17-5p-JAK1 axis in AML

Authors: Miaomiao Liu, Bingxin Yu, Yong Tian, Fan Li

Published in: BMC Cancer | Issue 1/2024

Abstract

Acute myeloid leukemia (AML), characterized by the abnormal accumulation of immature marrow cells in the bone marrow, is a malignant tumor of the blood system. Currently, the pathogenesis of AML is not yet clear. Therefore, this study aims to explore the mechanisms underlying the development of AML. Firstly, we identified a competing endogenous RNA (ceRNA) SUCLG2-AS1-miR-17-5p-JAK1 axis through bioinformatics analysis. Overexpression of SUCLG2-AS1 inhibits proliferation, migration and invasion and promotes apoptosis of AML cells. Secondly, luciferase reporter assay and RIP assay validated that SUCLG2-AS1 functioned as ceRNA for sponging miR-17-5p, further leading to JAK1 underexpression. Additionally, the results of MeRIP-qPCR and m6A RNA methylation quantification indicted that SUCLG2-AS1(lncRNA) had higher levels of m6A RNA methylation compared with controls, and SUCLG2-AS1 is regulated by m6A modification of WTAP in AML cells. WTAP, one of the main regulatory components of m6A methyltransferase complexes, proved to be highly expressed in AML and elevated WTAP is associated with poor prognosis of AML patients. Taken together, the WTAP-SUCLG2-AS1-miR-17-5p-JAK1 axis played essential roles in the process of AML development, which provided a novel therapeutic target for AML.

Available only for authorised users

Aung MMK, Mills ML, Bittencourt-Silvestre J, Keeshan K. Insights into the molecular profiles of adult and paediatric acute myeloid leukaemia. Mol Oncol. 2021;15:2253–72. https://doi.org/10.1002/1878-0261.12899.CrossRefPubMedPubMedCentral

Wang XN, Studzinski GP. Activation of extracellular signal-regulated kinases (ERKs) defines the first phase of 1,25-dihydroxyvitamin D-3-induced differentiation of HL60 cells. J Cell Biochem. 2001;80:471–82. https://doi.org/10.1002/1097-4644(20010315)80:4<471::Aid-jcb1001>3.0.Co;2-j.

Fathi AT, Chen Y-B. Treatment of relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation. Curr Hematol Malig Rep. 2014;9:186–92. https://doi.org/10.1007/s11899-014-0209-2.CrossRefPubMed

Pedersen-Bjergaard J, Christiansen DH, Desta F, Andersen MK. Alternative genetic pathways and cooperating genetic abnormalities in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia. Leukemia. 2006;20:1943–9. https://doi.org/10.1038/sj.leu.2404381.CrossRefPubMed

Yan H, Wen L, Tan D, Xie P, Pang FM, Zhou HH, Zhang W, Liu ZQ, Tang J, Li X, Chen XP. Association of a cytarabine chemosensitivity related gene expression signature with survival in cytogenetically normal acute myeloid leukemia. Oncotarget. 2017;8:1529–40. https://doi.org/10.18632/oncotarget.13650.CrossRefPubMed

Mertes F, ElSharawy A, Sauer S, van Helvoort JMLM, van der Zaag PJ, Franke A, Nilsson M, Lehrach H, Brookes AJ. Targeted enrichment of genomic DNA regions for next-generation sequencing. Brief Funct Genomics. 2011;10:374–86. https://doi.org/10.1093/bfgp/elr033.CrossRefPubMedPubMedCentral

Zaghlool A, Niazi A, Bjorklund AK, Westholm JO, Ameur A, Feuk L. Characterization of the nuclear and cytosolic transcriptomes in human brain tissue reveals new insights into the subcellular distribution of RNA transcripts. Sci Rep. 2021;11:11. https://doi.org/10.1038/s41598-021-83541-1.CrossRef

Kong H, Sun ML, Zhang XA, Wang XQ. Crosstalk among circRNA/lncRNA, miRNA, and mRNA in Osteoarthritis. Front Cell Dev Biol. 2021;9. https://doi.org/10.3389/fcell.2021.774370.

Leng Y, Wang MZ, Xie KL, Cai Y. Identification of potentially functional circular RNA/long noncoding RNA-MicroRNA-mRNA regulatory networks associated with vascular injury in type 2 diabetes mellitus by integrated microarray analysis. J Diabetes Res. 2023;2023:3720602. https://doi.org/10.1155/2023/3720602.CrossRefPubMedPubMedCentral

10.

Wu YG, Lu XX, Shen B, Zeng Y. The therapeutic potential and role of miRNA, lncRNA, and circRNA in Osteoarthritis. Curr Gene Ther. 2019;19:255–63. https://doi.org/10.2174/1566523219666190716092203.CrossRefPubMed

11.

Bai Y, Lu W, Han N, Bian H, Zhu M. Functions of miR126 and innate immune response. Yi Chuan. 2014;36:631–6. https://doi.org/10.3724/sp.J.1005.2014.0631.CrossRefPubMed

12.

Zhou W, Xue P, Yang Y, Xia L, Yu B. Research progress on N6-methyladenosine in the human placenta. J Perinat Med. 2022. https://doi.org/10.1515/jpm-2021-0665.CrossRefPubMed

13.

Yi YC, Chen XY, Zhang J, Zhu JS. Novel insights into the interplay between m6A modification and noncoding RNAs in cancer. Mol Cancer. 2020;19. https://doi.org/10.1186/s12943-020-01233-2.

14.

Ma S, Chen C, Ji X, Liu J, Zhou Q, Wang G, Yuan W, Kan Q, Sun Z. The interplay between m6A RNA methylation and noncoding RNA in cancer. J Hematol Oncol. 2019;12:121. https://doi.org/10.1186/s13045-019-0805-7.CrossRefPubMedPubMedCentral

15.

Qin Y, Li L, Luo E, Hou J, Yan G, Wang D, Qiao Y, Tang C. Role of m6A RNA methylation in cardiovascular disease (review). Int J Mol Med. 2020;46:1958–72. https://doi.org/10.3892/ijmm.2020.4746.CrossRefPubMedPubMedCentral

16.

McHugh CA, Chen CK, Chow A, Surka CF, Tran C, McDonel P, Pandya-Jones A, Blanco M, Burghard C, Moradian A, Sweredoski MJ, Shishkin AA, Su JL, Lander ES, Hess S, Plath K, Guttman M. The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3. Nature. 2015;521:232. https://doi.org/10.1038/nature14443.CrossRefPubMedPubMedCentral

17.

Yang LL, Zhao RR, Jiang RY, Liu H, Zhou SY, Gu B, Wu XJ, Wu DP. The expression of WTAP gene in acute myeloid leukemia and its clinical significance. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021;29:653–60. https://doi.org/10.19746/j.cnki.issn.1009-2137.2021.03.001.CrossRefPubMed

18.

Yang LR, Lin ZY, Hao QG, Li TT, Zhu Y, Teng ZW, Zhang J. The prognosis biomarkers based on m6A-related lncRNAs for myeloid leukemia patients. Cancer Cell Int. 2022;22:22. https://doi.org/10.1186/s12935-021-02428-3.CrossRef

19.

Shi L, Li WL, Zeng HX, Shi Y, Liao XL. Systematic identification and functional analysis of long noncoding RNAs involved in indoxacarb resistance in Spodoptera litura. Insect Sci. 2022. https://doi.org/10.1111/1744-7917.13015.CrossRefPubMed

20.

Wang KX, Chen CB, Wan QX, Zha XF. Long non-coding RNA Bmdsx-AS1 effects on male external genital development in silkworm. Insects. 2022;13:188. https://doi.org/10.3390/insects13020188.CrossRefPubMedPubMedCentral

21.

Li J, Wang J, Zhong Y, Guo R, Chu D, Qiu H, Yuan Z. HOTAIR: a key regulator in gynecologic cancers. Cancer Cell Int. 2017;17:65. https://doi.org/10.1186/s12935-017-0434-6.CrossRefPubMedPubMedCentral

22.

Yang MH, Zhao L, Wang L, Wen OY, Hu SS, Li WL, Ai ML, Wang YQ, Han Y, Li TT, Ding YQ, Wang S. Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and Metastasis via inhibiting HOXD3-induced integrin 3 transcriptional activating and MAPK/AKT signalling. Mol Cancer. 2019;18. https://doi.org/10.1186/s12943-019-0955-9.

23.

Yang W, Zhou J, Zhang K, Li L, Xu Y, Ma K, Xie H, Cai L, Gong Y, Gong K. Identification and validation of the clinical roles of the VHL-related LncRNAs in clear cell renal cell carcinoma. J Cancer. 2021;12:2702–14. https://doi.org/10.7150/jca.55113.CrossRefPubMedPubMedCentral

24.

Zhang Q, Yan YF, Lv Q, Li YJ, Wang RR, Sun GB, Pan L, Hu JX, Xie N, Zhang C, Tian BC, Jiao F, Xu S, Wang PY, Xie SY. miR-4293 upregulates lncRNA WFDC21P by suppressing mRNA-decapping enzyme 2 to promote lung carcinoma proliferation. Cell Death Dis. 2021;12:12. https://doi.org/10.1038/s41419-021-04021-y.CrossRefPubMedPubMedCentral

25.

Beer L, Nemec L, Wagner T, Ristl R, Altenburger LM, Ankersmit HJ, Mildner M. Ionizing radiation regulates long non-coding RNAs in human peripheral blood mononuclear cells. J Radiat Res. 2017;58:201–9. https://doi.org/10.1093/jrr/rrw111.CrossRefPubMed

26.

Matuszyk J. MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy. Mol Med. 2022;28:28. https://doi.org/10.1186/s10020-022-00516-2.CrossRef

27.

Fang L, Wang K. Identification of copy number variants from SNP arrays using PennCNV. Methods Mol Biol. 2018;1833:1–28. https://doi.org/10.1007/978-1-4939-8666-8_1.CrossRefPubMed

28.

Yoshida M, Kobune M, Miura S, Ibata S, Iyama S, Sato T, Murase K, Takada K, Ono K, Hashimoto A, Tatekoshi A, Kamihara Y, Sugama Y, Kikuchi S, Ikeda H, Horiguchi H, Kawano Y, Miyanishi K, Kuroda H, Maeda M, Kato J. Extracellular vesicle microRNAs from acute myeloid leukemia are involved in the regulation of adherence junction in bone marrow microenvironment. Blood. 2016;128. https://doi.org/10.1182/blood.V128.22.2863.2863.

29.

Chen XM, Zhang HM, Yang B, Lu XC, He PF. Analysis of unfavorable prognosis gene markers in patients with acute myeloid leukemia by multiomics. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019;27:331–8. https://doi.org/10.19746/j.cnki.issn.1009-2137.2019.02.004.CrossRefPubMed

30.

Ito K, Murphy D. Application of ggplot2 to pharmacometric graphics. CPT Pharmacometrics Syst Pharmacol. 2013;2(10):e79.CrossRefPubMedPubMedCentral

31.

Abdi S, Zamanian Azodi M, Rezaei-Tavirani M, Razzaghi M, Heidari MH, Akbarzadeh Baghban A. Differentiation of H. Pylori-negative and positive gastric cancer via regulatory network analysis. Gastroenterol Hepatol Bed Bench. 2020;13:161–7.PubMedPubMedCentral

32.

Chen C, Li L, Zhao C, Zhen J, Yan J. Analysis of sepsis-related genes through weighted gene co-expression network. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021;33:659–64. https://doi.org/10.3760/cma.j.cn121430-20210127-00135.CrossRefPubMed

33.

Jiang DF, Wu X, Sun XY, Tan W, Dai X, Xie YB, Du AS, Zhao QQ. Bone mesenchymal stem cell-derived exosomal microRNA-7-5p inhibits progression of acute myeloid leukemia by targeting OSBPL11. J Nanobiotechnol. 2022;20(1):29. https://doi.org/10.1186/s12951-021-01206-7.CrossRef

34.

Dang YQ, Xu JJ, Yang Y, Li CL, Zhang Q, Zhou WJ, Zhang L, Ji G. Ling-gui-zhu-gan decoction alleviates hepatic steatosis through SOCS2 modification by N6-methyladenosine. Biomed Pharmacother. 2020;127. https://doi.org/10.1016a./j.bioph2020.109976.

35.

Nadarajan G, Doyle S. Realistic cross-domain microscopy via conditional generative adversarial networks: converting immunofluorescence to hematoxylin and Eosin, SPIE Conference on medical imaging - digital pathology, Houston, TX. 2020.

36.

Alspach E, Stewart SA. RNA-binding Protein Immunoprecipitation (RIP) to examine AUF1 binding to Senescence-Associated Secretory Phenotype (SASP) factor mRNA. Bio Protoc. 2015;5(10):e1481.CrossRefPubMed

37.

Dang WQ, Tang H, Cao H, Wang L, Chen TM. Construction of lentivirus-mediated short hairpin RNA targeting human STAT3 gene. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012;28:1204–7.PubMed

38.

Liao R, Cao JF. Emodin induces osteosarcoma cell apoptosis by promoting ATM protein cleavage. Trop J Pharm Res. 2023;22:31–6. https://doi.org/10.4314/tjpr.v22i1.5.CrossRef

39.

Zhao C, Zhang J, Yang ZY, Shi LQ, Liu SL, Pan LJ, Dong P, Zhang Y, Xiang SS, Shu YJ, Mei JW. Ponicidin inhibited gallbladder cancer proliferation and Metastasis by decreasing MAGEB2 expression through FOXO4. Phytomedicine. 2023;114. https://doi.org/10.1016/j.phymed.2023.154785.

40.

Zhang Q, Lu MY, Wang C, Du J, Zhou PX, Zhao MR. Characterization of estrogen receptor α activities in polychlorinated biphenyls by in vitro dual-luciferase reporter gene assay. Environ Pollut. 2014;189:169–75. https://doi.org/10.1016/j.envpol.2014.03.001.CrossRefPubMed

41.

Zhang Z, Li SY, Zhang LB. LncRNA RGMB-AS1 is activated by E2F1 and promotes cell proliferation and invasion in papillary thyroid carcinoma. Eur Rev Med Pharmacol Sci. 2018;22:1979–86.PubMed

42.

Hong JW, Yu Y, Wang LS, Li Z, Zhang R, Wang Q, Ding Z, Zhang JP, Zhang MR, Xu LC. BMP4 regulates EMT to be involved in non-syndromic cleft lip with or without palate. Cleft Palate Craniofac J. 2022. https://doi.org/10.1177/10556656221105762.CrossRefPubMed

43.

Xiang ZF, Zhao Y, Mitaksov V, Fremont DH, Kasai Y, Molitoris A, Ries RE, Miner TL, McLellan MD, DiPersio JF, Link DC, Payton JE, Graubert T, Watson M, Shannon W, Heath SE, Nagarajan R, Mardis ER, Wilson RK, Ley TJ, Tomasson MH. Identification of somatic JAK1 mutations in patients with acute myeloid leukemia. Blood. 2008;111:4809–12. https://doi.org/10.1182/blood-2007-05-090308.CrossRefPubMedPubMedCentral

44.

Jiang CX, Qu XY, Ke HH, Gong W, Chen R, Yang WH, Cheng ZP. Association between the HMGB1/TLR4 signaling pathway and the clinicopathological features of Ovarian cancer. Mol Med Rep. 2018;18:3093–8. https://doi.org/10.3892/mmr.2018.9271.CrossRefPubMed

45.

Tang ZL, Zhang K, Lv SC, Xu GW, Zhang JF, Jia HY. LncRNA MEG3 suppresses PI3K/AKT/mTOR signalling pathway to enhance autophagy and inhibit inflammation in TNF-α-treated keratinocytes and psoriatic mice. Cytokine. 2021;148. https://doi.org/10.1016/j.cyto.2021.155657.

46.

Naren D, Yan TY, Gong YP, Huang JC, Zhang D, Sang LN, Zheng X, Li YR. High Wilms’ Tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m6a methylation of MYC mRNA. J Cancer Res Clin Oncol. 2021;147:33–47. https://doi.org/10.1007/s00432-020-03373-w.CrossRefPubMed

47.

Duan Y, Yu C, Yan MP, Ouyang YZ, Ni SJ. m6A regulator-mediated RNA methylation modification patterns regulate the immune microenvironment in osteoarthritis. Front Genet. 2022;13. https://doi.org/10.3389/fgene.2022.921256.

48.

Guo LL, Song CH, Wang P, Dai LP, Zhang JY, Wang KJ. Competing endogenous RNA networks and gastric cancer. World J Gastroenterol. 2015;21:11680–7. https://doi.org/10.3748/wjg.v21.i41.11680.CrossRefPubMedPubMedCentral

49.

Gu Y, Lin Y, Li M, Zong C, Sun H, Shen Y, Zhu J. An analysis of lncRNA-miRNA-mRNA networks to investigate the effects of HDAC4 inhibition on skeletal muscle atrophy caused by peripheral nerve injury. Ann Transl Med. 2022;10(9):516. https://doi.org/10.21037/atm-21-6512.CrossRefPubMedPubMedCentral

50.

Liu SS, Zhang JF, Yin LY, Wang XX, Zheng Y, Zhang YJ, Gu JY, Yang L, Yang J, Zheng P, Jiang Y, Shuai L, Cai XW, Wang HZ. The lncRNA RUNX1-IT1 regulates C-FOS transcription by interacting with RUNX1 in the process of pancreatic cancer proliferation, migration and invasion. Cell Death Dis. 2020;11. https://doi.org/10.1038/s41419-020-2617-7.

51.

Fang T, Wu Q, Zhou L, Mu S, Fu Q. miR-106b-5p and mir-17-5p suppress osteogenic differentiation by targeting Smad5 and inhibit bone formation. Exp Cell Res. 2016;347:74–82. https://doi.org/10.1016/j.yexcr.2016.07.010.CrossRefPubMed

52.

Soliman RA, Youness RA, Manie TM, Khallaf E, El-Shazly M, Abdelmohsen M, Handoussa H, Gad MZ. Uncoupling tumor necrosis factor-alpha and interleukin-10 at tumor immune microenvironment of breast cancer through miR-17-5p/MALAT-1/H19 circuit. Biocell. 2022;46:769–83. https://doi.org/10.32604/biocell.2022.016636.CrossRef

53.

Liu F, Su X. Effects of m6A modifications on signaling pathways in human cancer. Oncol Rep. 2021;45. https://doi.org/10.3892/or.2021.7987.

54.

Teng FZ, Tang WF, Wuniqiemu T, Qin JJ, Zhou YL, Huang X, Wang SY, Zhu XY, Tang Z, Yi L, Wei Y, Dong JC. Methyladenosine methylomic landscape of lung tissues in murine acute allergic asthma. Front Immunol. 2021;12. https://doi.org/10.3389/fimmu.2021.740571.

55.

Lan YF, Liu BY, Guo HB. The role of M6A modification in the regulation of tumor-related lncRNAs. Mol Ther Nucleic Acids. 2021;24:768–79. https://doi.org/10.1016/j.omtn.2021.04.002.CrossRefPubMedPubMedCentral

56.

Zhang BJ, Jiang H, Dong Z, Sun AJ, Ge JB. The critical roles of m6A modification in metabolic abnormality and cardiovascular diseases. Genes Dis. 2021;8:746–58. https://doi.org/10.1016/j.gendis.2020.07.011.CrossRefPubMed

57.

Horiuchi K, Kawamura T, Hamakubo T. Wilms’ tumor 1-associating protein complex regulates alternative splicing and polyadenylation at potential G-quadruplex-forming splice site sequences. J Biol Chem. 2021;297:101248. https://doi.org/10.1016/j.jbc.2021.101248.CrossRefPubMedPubMedCentral

Title: Regulatory function and mechanism research for m6A modification WTAP via SUCLG2-AS1- miR-17-5p-JAK1 axis in AML
Authors: Miaomiao Liu
Bingxin Yu
Yong Tian
Fan Li
Publication date: 01-12-2024
Publisher: BioMed Central
Keyword: Acute Myeloid Leukemia
Published in: BMC Cancer / Issue 1/2024
Electronic ISSN: 1471-2407
DOI: https://doi.org/10.1186/s12885-023-11687-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2024

Imprinted gene detection effectively improves the diagnostic accuracy for papillary thyroid carcinoma

Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22–09

Comprehensive analysis the prognostic and immune characteristics of mitochondrial transport-related gene SFXN1 in lung adenocarcinoma

Knockdown of NCAPD3 inhibits the tumorigenesis of non-small cell lung cancer by regulation of the PI3K/Akt pathway

m1A regulator-mediated methylation modification patterns correlated with autophagy to predict the prognosis of hepatocellular carcinoma

Cancer-associated fibroblasts drive colorectal cancer cell progression through exosomal miR-20a-5p-mediated targeting of PTEN and stimulating interleukin-6 production

Keynote webinar | Spotlight on antibody–drug conjugates in cancer